Abstract
T lymphocytes are primary effector cells of cell-mediated immunity as well as regulators of growth (clonal expansion) and differentiation of the immune system. Until less than a decade ago, their regulatory activity was presumed to be attributed to predominantly cellular interactions mediated by membrane-bound recognitive elements often associated with the major histocompatibility (H2 or HLA) complex. Recently, in the historical context of the development of immunological models, many regulatory functions of T lymphocytes appear to be mediated by molecules secreted by various functionally distinct subpopulations of lymphoid and nonlymphoid cells. Indeed, the principle regulatory cells of the immune system, T lymphocytes, are also under the regulatory influence of specific monocyte/ macrophage derived cytokines referred to as monokines. In addition to regulating lymphocyte activities, there is considerable evidence that lymphocyte-derived molecules, lymphokines, influence the differentiation of hematopoietic cells, mast cells, fibroblasts, and osteoclasts1–6. This suggests that the regulatory cytokines produced by specific antigen may also effect hematopoietic homeostasis as well as inflammatory cells involved in immediate hypersensitivities. Lymphokines are considered to be actively synthesized (transcription of DNA) and secreted by either native lymphoid cells or their malignant cell line counterparts (macrophage or lymphocyte). While normal lymphoid tissues or cells must be activated by antigen or polyclonal stimulation to produce lymphokines, some longterm cell lines have been fortuitously shown to constitutively secrete lymphokines. Indeed, such cell lines have been critical for providing the genetic library for the recombinant DNA cloning of several lymphokines. Lymphokines provide nonspecific augmentation to antigen-specific responses. Lymphokines can generally be readily separated by conventional biochemical chromatography, but standard 280 nm absorbance and protein stains have been of little value since they are usually present in culture media in nanomolar concentrations. Finally, with the introduction of monoclonal antibodies, several lymphokines may be neutralized and quantitated in vitro by specific antibody.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R. W. Ruscetti, R. H. Cypess, and P. S. Chervenick, Blood 47: 757 (1976).
J. J. Oppenheim and I. Gery, Immunology Today 3: 113 (1982).
K. Tadokoro, B. M. Stadler and A. L. DeWeck, J. Exp. Med. 158:857 (1983).
J. W. Adamson, W. J. Dopovic and J. E. Brown, in: “Hematopoitetic Cell Differentiation,” D. W. Golde, M. J. Cline, D. Metcalf, C. F. Fox, eds., Academic Press, New York (1978).
A. W. Burgess, D. Metcalf, N. A. Nicola and S.H.M. Russel, in: “Hematopoietic Cell Differentiation,” D. W. Golde, M. J. Cline, D. Metcalf, C. F. Fox, eds., Academic Press, New York (1978).
Y. P. Yung, R. Eger, G. Tertian and M.A.S. Moore, J. Immunol. 127: 794 (1981).
J. J. Farrar and J. Fuller-Bonar, J. Immunol. 117:274 (1976).
J. J. Farrar, W. J. Koopman and J. Fuller-Bonar, J. Immunol. 114:47 (1977).
J. J. Farrar, P. L. Simon, W. J. Koopman and J. F. Bonar, J. Immunol. 121: 1353 (1978).
D. D. Wood, J. Immunol. 123: 2400 (1979).
W. L. Farrar, S. B. Mizel and J. J. Farrar, J. Immunol. 124: 1371 (1980).
S. Gillis, P. E. Baker, F. W. Ruscetti and K. A. Smith, J. Exp. Med. 154:983 (1978).
J. J. Farrar, W. R. Benjamin, M. L. Hilfker, M. Howard, W. L. Farrar and J. Fuller-Farrar, Immunol. Rev. 63:129 (1982).
R. W. Ruscetti, D. A. Morgan and R. C. Gallo, J. Immunol. 122: 2527 (1979).
S. B. Mizel and D. L. Rosenstreich, J. Immunol. 122:2173 (1979).
J. J. Farrar, J. Fuller-Farrar, P. L. Simon, M. L. Hilfiker, B. M. Stadler and W. L. Farrar, J. Immunol. 125: 2555 (1980a).
J. J. Farrar, S. B. Mizel, J. Fuller-Bonar, M. L. Hllfiker and W. L. Farrar, Microbiol. 36: 39 (1980b).
K. A. Smith, L. B. Lachman, J. J. Oppenheim and M. F. Favata, J. Exp. Med. 151: 1551 (1980).
E. L. Larsson, N. N. Iscove and A. Coutinho, Nature 283: 664 (1980).
R. N. Moore, J. J. Oppenheim, J. J. Farrar, C. S. Carter, A. Waheed and R. K. Shadduck, J. Immunol. 3: 119 (1980).
R. N. Moore, J. T. Haffeld, J. J. Farrar, S. E. Mergenhagen, J. J. Oppenheim and R. K. Shadduck, Lymphokines 3: 119 (1981).
W. L. Farrar, H. M. Johnson and J. J. Farrar, J. Immunol. 126: 1120 (1981).
C. S. Henney, K. Kuribaysashi, D. E. Kern and S. Gillis, Nature 291: 335 (1981).
W. Domzig, B. M. Stadler and R. B. Herberman, J. Immunol. 130:1970 (1983).
D. A. Weignet, G. J. Stanton and H. M. Johnson, Infect. Immun. 41:992 (1983).
H. M. Johnson and W. L. Farrar, Cell. Immunol. 75:154 (1983).
P. S. Steeg, R. N. Moore, H. M. Johnson and J. J. Oppenheim, J. Exp. Med. 156:1780 (1983).
T. Y. Basham and T. C. Merigan, J. Immunol. 130: 1492 (1983).
B. Harfest, J. R. Huddleston, P. Casali, T. C. Merigun and M.B.A. Olstone, J. Immunol. 127: 2146 (1981).
D. N. Mannel and W. Falk, Cell. Immunol. 79: 396 (1983).
J. R. Ortaldo, A. Mantovani, D. Hobbs, M. Rubinstein, S. Pestica and R. B. Herberman, Int. J. Cancer 31:285 (1983).
M. C. Howard, J. Farrar, M. Hilfiker, B. Johnson, T. Takatsu and W. L. Paul, J. Exp. Med. 155:914 (1982).
A. Schimpl and W. Wicker, Nature 237: 15 (1972).
T. Kasahara, J. Y. Djeu, S. F. Dougherty and J. J. Oppenheim, J. Immunol. 131: 2379 (1983).
A. Hapel, J. C. Lee, W. L. Farrar and J. W. Ihle, Cell 25: 179 (1981).
J. W. Schrader and I. Clark-Lewis, J. Immunol. 129:30 (1982).
E. Hazum, K-J. Chang and P. Cuatrecasas, Science 205: 1033 (1979).
S. C. Gilman, J. M. Schwartz, R. J. Milner, F. E. Bloom and J. D. Feldman, PNAS 79: 4226 (1982).
P. M. Mathews, C. J. Froelich, W. L. Sibbitt and A. D. Bankhurst, J. Immunol. 130:1658 (1983).
Y. Yamasaki, K. Shimamura, A. Kizu, M. Nakagawa and H. Ijichi, Life Sciences 31: 471 (1982).
H.O.J. Cailler and A. C. Roy, Nature 248: 24 (1974).
R. S. Childers, S. M. Lambert and G. LaRiviere, Life Sciences 33: 215 (1983).
R. D. Maca, Immunopharmacol. 6: 267 (1983).
P. E. Baker, J. V. Fahey and A. Munck, J. Exp. Med. 61:52 (1981).
P. N. Shek and B. H. Sabiston, Int. J. Immunopharmacol. 5:23 (1983).
C. I. Thompson, J. W. Kreider, P. L. Black, T. J. Schmidt and D. L. Margules, Science 220: 1183 (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer Science+Business Media New York
About this chapter
Cite this chapter
Farrar, W.L. (1986). Relationship between Lymphokine and Opiatergic Modulation of Lymphocyte Proliferation. In: Plotnikoff, N.P., Faith, R.E., Murgo, A.J., Good, R.A. (eds) Enkephalins and Endorphins. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0557-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0557-4_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0559-8
Online ISBN: 978-1-4899-0557-4
eBook Packages: Springer Book Archive